stockportfolio.pro
AbbVie Inc. Free Cash Flow 2011–2025
AbbVie Inc. (ABBV) annual free cash flow by fiscal year, computed from SEC filings. Compound growth +8.2%/yr over 14 years.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $17.82B | -0.1% |
| FY 2024 | $17.83B | -19.2% |
| FY 2023 | $22.06B | -9.0% |
| FY 2022 | $24.25B | +10.3% |
| FY 2021 | $21.99B | +31.0% |
| FY 2020 | $16.79B | +31.5% |
| FY 2019 | $12.77B | -0.1% |
| FY 2018 | $12.79B | +35.6% |
| FY 2017 | $9.43B | +43.7% |
| FY 2016 | $6.56B | -6.3% |
| FY 2015 | $7.00B | +138.4% |
| FY 2014 | $2.94B | -49.2% |
| FY 2013 | $5.78B | -3.9% |
| FY 2012 | $6.01B | +2.1% |
| FY 2011 | $5.89B | — |
Source: AbbVie Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for AbbVie Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbVie Inc. — frequently asked questions
What is AbbVie Inc.'s free cash flow?
AbbVie Inc. (ABBV) reported free cash flow of $17.82B for fiscal year 2025, per its SEC filings.
How has AbbVie Inc.'s free cash flow changed over time?
Between fiscal 2011 and 2025, ABBV's free cash flow grew at roughly 8.2% per year (compound annual rate), from $5.89B to $17.82B.
Where does this data come from?
Figures are computed from AbbVie Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.